# Intravenous Versus Oral Iron Therapy in Hemodialysis Patients

> **NCT04464850** · PHASE3 · UNKNOWN · sponsor: **Chiang Mai University** · enrollment: 124 (estimated)

## Conditions studied

- Hemodialysis Complication
- Anemia
- Iron Deficiency Anemia

## Interventions

- **DRUG:** Intravenous iron
- **DRUG:** Oral iron

## Key facts

- **NCT ID:** NCT04464850
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-29
- **Primary completion:** 2021-01-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464850, "Intravenous Versus Oral Iron Therapy in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04464850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*